Latest News about RARE
Recent news which mentions RARE
Analyst Bullish On Ultragenyx, Poised For Growth With Six Drug Approvals Expected By 2028
May 28, 2025
From Benzinga
Earnings Scheduled For May 6, 2025
May 06, 2025
From Benzinga
From Benzinga
Ultragenyx Stays On JPMorgan's Focus List As Analyst Highlights Strong Long-Term Positioning
March 27, 2025
From Benzinga
Breaking Down Ultragenyx Pharmaceutical: 7 Analysts Share Their Views
February 14, 2025
Tickers
RARE
From Benzinga
Earnings Scheduled For February 13, 2025
February 13, 2025
From Benzinga
Ultragenyx's Multiple Commercial Assets And Candidates Impress Analyst; Sees Solid Upside
January 15, 2025
From Benzinga
From Benzinga
Evaluating Ultragenyx Pharmaceutical: Insights From 7 Financial Analysts
November 06, 2024
Tickers
RARE
From Benzinga
A Look Ahead: Ultragenyx Pharmaceutical's Earnings Forecast
November 04, 2024
Tickers
RARE
From Benzinga
Decoding 10 Analyst Evaluations For Ultragenyx Pharmaceutical
October 21, 2024
Tickers
RARE
From Benzinga
Breaking Down Ultragenyx Pharmaceutical: 10 Analysts Share Their Views
September 20, 2024
Tickers
RARE
From Benzinga
Novartis And Viatris Sued Over Unlawful Use Of HeLa Cells Used For Cancer Treatment Drugs
August 06, 2024
From Benzinga
3 Genomics Stocks That May Transform Personalized Medicine
August 06, 2024
From InvestorPlace
Ionis' Rare Development Disorder Drug Candidate 'Could Be Differentiated' From Peer Ultragenyx: Analyst
July 22, 2024
From Benzinga
From InvestorPlace
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 14, 2024
From Benzinga
Dave & Buster's Posts Downbeat Results, Joins J.Jill And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
June 13, 2024
From Benzinga
From Benzinga
From Benzinga
Tickers
RARE
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.